Curis, Inc.
CRIS
$1.67
$0.021.21%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/22/2025
-
TipRanks Financial Blog
8/11/2025
-
The Fly
8/8/2025
-
TipRanks Financial Blog
8/8/2025
-
Simply Wall St
8/6/2025
-
GuruFocus
8/6/2025
-
Insider Monkey
8/6/2025
-
GuruFocus
8/6/2025
-
Ticker Report
8/6/2025
-
TipRanks Financial Blog
8/5/2025
-
Fool.com Headlines
8/5/2025
-
Seeking Alpha: Transcripts
8/5/2025
-
GuruFocus
8/5/2025
-
Zacks Investment Research
8/5/2025
-
GuruFocus
8/5/2025
-
GuruFocus
8/5/2025
-
PR Newswire
8/4/2025
-
Benzinga
8/4/2025
-
GuruFocus
7/29/2025
-
GuruFocus
7/29/2025
-
GuruFocus
7/29/2025
-
PR Newswire
7/3/2025
-
Simply Wall St
7/2/2025
-
GuruFocus
7/2/2025
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 5, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 503 6500
Address
Building C
Suite 500 - 128 Spring Street
Lexington, MA 02421
Suite 500 - 128 Spring Street
Lexington, MA 02421
Country
Year Founded
Business Description
Sector
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates...
more